2025
SJR Q2
JCR Q4 · 2
207 matched articles
SCIE
Journal detail
Tumori
- Publisher
- Wichtig Publishing Srl
- Country
- Italy · Western Europe
- Type
- journal
- ISSN
-
0300891620382529
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,574
- Quartile Q2
- H-Index 60
- Cites/doc 1,69
- Docs (3y) 227
- Cites (3y) 401
Clarivate
Web of Science · JCR · 2025
- JCR Q Q4
- JIF 2
- 5Y JIF 2,3
- JCI 0,36
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cancer Research Q3
- Medicine (miscellaneous) Q2
- Oncology Q3
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS categories
- Oncology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q4 | 0,574 | 2 | 2,3 | 0,36 | Q4 | 60 |
| 2024 | Q2 | Q2 | 0,535 | 3,1 | 2,3 | 0,41 | Q3 | 59 |
| 2023 | Q3 | Q3 | 0,466 | 2,4 | 1,9 | 0,36 | Q4 | 59 |
| 2022 | Q3 | Q4 | 0,443 | 2,3 | 1,9 | 0,34 | Q4 | 59 |
| 2021 | Q3 | Q4 | 0,407 | 2,4 | 1,9 | 0,37 | Q4 | 59 |
| 2020 | Q3 | Q4 | 0,453 | 2,1 | 1,7 | 0,32 | Q4 | 59 |
| 2019 | Q3 | Q4 | 0,412 | 1,7 | 1,3 | 0,29 | Q4 | 59 |
| 2018 | — | Q4 | — | 1,2 | 1,1 | 0,24 | Q4 | — |
| 2017 | Q3 | Q4 | 0,396 | 1,3 | 1,2 | 0,23 | Q4 | 59 |
| 2016 | Q3 | Q4 | 0,367 | 1,2 | 1,3 | — | — | 59 |
| 2015 | Q2 | Q4 | 0,482 | 1,1 | 1,2 | — | — | 59 |
| 2014 | Q2 | Q4 | 0,458 | 1,3 | 1,1 | — | — | 59 |
| 2013 | Q2 | Q4 | 0,479 | 1,1 | 1,1 | — | — | 59 |
| 2012 | Q2 | Q4 | 0,413 | 0,9 | 1 | — | — | 59 |
| 2011 | Q2 | Q4 | 0,367 | 0,6 | 0,8 | — | — | 59 |
| 2010 | Q2 | Q4 | 0,404 | 1 | 1 | — | — | 59 |
| 2009 | — | Q4 | — | 0,9 | 0,9 | — | — | — |
| 2008 | — | Q4 | — | 0,8 | 0,8 | — | — | — |
| 2007 | — | Q4 | — | 0,6 | 0,7 | — | — | — |
| 2006 | — | Q4 | — | 0,7 | — | — | — | — |
| 2005 | — | Q4 | — | 0,7 | — | — | — | — |
| 2004 | — | Q4 | — | 0,6 | — | — | — | — |
| 2003 | — | Q4 | — | 0,3 | — | — | — | — |
| 2002 | — | Q4 | — | 0,3 | — | — | — | — |
| 2001 | — | Q4 | — | 0,5 | — | — | — | — |
| 2000 | — | Q4 | — | 0,5 | — | — | — | — |
| 1999 | — | Q4 | — | 0,6 | — | — | — | — |
| 1998 | — | Q4 | — | 0,6 | — | — | — | — |
| 1997 | — | Q4 | — | 0,4 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ONCOLOGY | SCIE | Q4 | Q4 | 250/333 |
| 2024 | ONCOLOGY | SCIE | Q2 | Q3 | 142/328 |
| 2023 | ONCOLOGY | SCIE | Q3 | Q4 | 194/322 |
| 2022 | ONCOLOGY | SCIE | Q4 | Q4 | 196/241 |
| 2021 | ONCOLOGY | SCIE | Q4 | Q4 | 204/245 |
| 2020 | ONCOLOGY | SCIE | Q4 | Q4 | 222/242 |
| 2019 | ONCOLOGY | SCIE | Q4 | Q4 | 220/244 |
| 2018 | ONCOLOGY | SCIE | Q4 | Q4 | 217/230 |
| 2017 | ONCOLOGY | SCIE | Q4 | Q4 | 207/223 |
| 2016 | ONCOLOGY | SCIE | Q4 | — | 197/217 |
| 2015 | ONCOLOGY | SCIE | Q4 | — | 195/213 |
| 2014 | ONCOLOGY | SCIE | Q4 | — | 184/211 |
| 2013 | ONCOLOGY | SCIE | Q4 | — | 178/203 |
| 2012 | ONCOLOGY | SCIE | Q4 | — | 177/197 |
| 2011 | ONCOLOGY | SCIE | Q4 | — | 178/196 |
| 2010 | ONCOLOGY | SCIE | Q4 | — | 157/185 |
| 2009 | ONCOLOGY | SCIE | Q4 | — | 146/166 |
| 2008 | ONCOLOGY | SCIE | Q4 | — | 138/143 |
| 2007 | ONCOLOGY | SCIE | Q4 | — | 128/132 |
| 2006 | ONCOLOGY | SCIE | Q4 | — | 121/127 |
| 2005 | ONCOLOGY | SCIE | Q4 | — | 116/123 |
| 2004 | ONCOLOGY | SCIE | Q4 | — | 115/123 |
| 2003 | ONCOLOGY | SCIE | Q4 | — | 116/120 |
| 2002 | ONCOLOGY | SCIE | Q4 | — | 110/114 |
| 2001 | ONCOLOGY | SCIE | Q4 | — | 101/107 |
| 2000 | ONCOLOGY | SCIE | Q4 | — | 98/103 |
| 1999 | ONCOLOGY | SCIE | Q4 | — | 91/105 |
| 1998 | ONCOLOGY | SCIE | Q4 | — | 86/104 |
| 1997 | ONCOLOGY | SCIE | Q4 | — | 85/102 |